{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:45:03Z","timestamp":1794473103693,"version":"4.9.1"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2022,8,1]]},"DOI":"10.1001\/jamaneurol.2022.1457","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T15:01:04Z","timestamp":1655823664000},"page":"739","source":"Crossref","is-referenced-by-count":29,"title":["Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry <i>CYP2C19<\/i> Loss-of-Function Alleles"],"prefix":"10.1001","volume":"79","author":[{"given":"Yuesong","family":"Pan","sequence":"first","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoming","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Claiborne","family":"Johnston","sequence":"additional","affiliation":[{"name":"Dell Medical School, University of Texas at Austin, Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Bath","sequence":"additional","affiliation":[{"name":"Stroke Trials Unit, Mental Health & Clinical Neuroscience, University of Nottingham, Nottingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxi","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingquan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jiyuan Hospital of Traditional Chinese Medicine, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwei","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Putuo District Central Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Taizhou First People\u2019s Hospital, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Advanced Innovation Center for Human Brain Protection, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"Research Unit of Artificial Intelligence in Cerebrovascular Disease, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"16","key":"noi220031r1","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1056\/NEJMoa1412981","article-title":"One-year risk of stroke after transient ischemic attack or minor stroke.","volume":"374","author":"Amarenco","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"noi220031r2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1001\/jamaneurol.2020.3627","article-title":"A 5-decade analysis of incidence trends of ischemic stroke after transient ischemic attack: a systematic review and meta-analysis.","volume":"78","author":"Shahjouei","year":"2021","journal-title":"JAMA Neurol"},{"issue":"12","key":"noi220031r3","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1001\/jamaneurol.2019.2531","article-title":"Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack: a pooled analysis of Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) trials.","volume":"76","author":"Pan","year":"2019","journal-title":"JAMA Neurol"},{"issue":"7","key":"noi220031r4","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association.","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"issue":"2","key":"noi220031r5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/svn-2020-000378","article-title":"Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases.","volume":"5","author":"Liu","year":"2020","journal-title":"Stroke Vasc Neurol"},{"issue":"2","key":"noi220031r6","doi-asserted-by":"publisher","first-page":"CLXXXVII","DOI":"10.1177\/23969873211000877","article-title":"European Stroke Organisation expedited recommendation for the use of short-term dual antiplatelet therapy early after minor stroke and high-risk TIA.","volume":"6","author":"Dawson","year":"2021","journal-title":"Eur Stroke J"},{"issue":"27","key":"noi220031r7","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1056\/NEJMoa2111749","article-title":"Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA.","volume":"385","author":"Wang","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"noi220031r8","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1161\/CIRCULATIONAHA.109.895342","article-title":"Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.","volume":"121","author":"Berger","year":"2010","journal-title":"Circulation"},{"issue":"6","key":"noi220031r9","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/ene.2016.23.issue-6","article-title":"Dual antiplatelet therapy after stroke or transient ischaemic attack\u2014how long to treat? the duration of aspirin plus clopidogrel in stroke or transient ischaemic attack: a systematic review and meta-analysis.","volume":"23","author":"Ge","year":"2016","journal-title":"Eur J Neurol"},{"issue":"2","key":"noi220031r10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/svn-2020-000791","article-title":"Clopidogrel With Aspirin in High-risk Patients With Acute Nondisabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial.","volume":"6","author":"Wang","year":"2021","journal-title":"Stroke Vasc Neurol"},{"issue":"1","key":"noi220031r11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jama.2016.8662","article-title":"Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack.","volume":"316","author":"Wang","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"noi220031r12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1136\/svn-2021-000874","article-title":"Analytical validation of GMEX rapid point-of-care CYP2C19 genotyping system for the CHANCE-2 trial.","volume":"6","author":"Meng","year":"2021","journal-title":"Stroke Vasc Neurol"},{"issue":"10","key":"noi220031r13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.","volume":"329","author":"GUSTO investigators","year":"1993","journal-title":"N Engl J Med"},{"issue":"11","key":"noi220031r14","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1161\/STROKEAHA.121.035555","article-title":"Ischemic benefit and hemorrhage risk of ticagrelor-aspirin versus aspirin in patients with acute ischemic stroke or transient ischemic attack.","volume":"52","author":"Johnston","year":"2021","journal-title":"Stroke"},{"issue":"20","key":"noi220031r15","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1212\/WNL.0000000000003941","article-title":"Risks and benefits of clopidogrel-aspirin in minor stroke or TIA: time course analysis of CHANCE.","volume":"88","author":"Pan","year":"2017","journal-title":"Neurology"},{"issue":"19","key":"noi220031r16","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.111.055079","article-title":"Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study.","volume":"125","author":"Friberg","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"noi220031r17","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1160\/TH09-11-0799","article-title":"Platelet function testing and risk of bleeding complications.","volume":"103","author":"Ferreiro","year":"2010","journal-title":"Thromb Haemost"},{"issue":"3","key":"noi220031r18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1056\/NEJMe1806043","article-title":"Antiplatelet therapy after ischemic stroke or TIA.","volume":"379","author":"Grotta","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"noi220031r19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"issue":"8","key":"noi220031r20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1161\/CIRCULATIONAHA.119.040713","article-title":"Time course for benefit and risk of clopidogrel and aspirin after acute transient ischemic attack and minor ischemic stroke.","volume":"140","author":"Johnston","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"noi220031r21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"noi220031r22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.116.024913","article-title":"Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis.","volume":"135","author":"Pan","year":"2017","journal-title":"Circulation"},{"issue":"10","key":"noi220031r23","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1161\/CIRCULATIONAHA.117.028566","article-title":"Risk for major bleeding in patients receiving ticagrelor compared with aspirin after transient ischemic attack or acute ischemic stroke in the SOCRATES study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).","volume":"136","author":"Easton","year":"2017","journal-title":"Circulation"},{"issue":"10123","key":"noi220031r24","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S0140-6736(17)32849-0","article-title":"Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.","volume":"391","author":"Bath","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"noi220031r25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.ahj.2015.03.015","article-title":"Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: a retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) trial.","volume":"169","author":"Kang","year":"2015","journal-title":"Am Heart J"},{"issue":"3","key":"noi220031r26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1747-4949.2006.00045.x","article-title":"Global burden of intracranial atherosclerosis.","volume":"1","author":"Wong","year":"2006","journal-title":"Int J Stroke"},{"issue":"3","key":"noi220031r27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1161\/STROKEAHA.113.003508","article-title":"Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study.","volume":"45","author":"Wang","year":"2014","journal-title":"Stroke"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2793534\/jamaneurology_pan_2022_oi_220031_1659710377.34554.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T15:06:27Z","timestamp":1659971187000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2793534"}},"subtitle":["A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2022.1457","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,1]]}}}